See more : Bluegreen Vacations Holding Corporation (BVH) Income Statement Analysis – Financial Results
Complete financial analysis of ASX Limited (ASXFF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ASX Limited, a leading company in the Financial – Data & Stock Exchanges industry within the Financial Services sector.
You may be interested
- Gran Tierra Energy Inc. (GTE.L) Income Statement Analysis – Financial Results
- Sunstone Hotel Investors, Inc. (SHO-PI) Income Statement Analysis – Financial Results
- Nam Securities Limited (NAM.BO) Income Statement Analysis – Financial Results
- Fintech Acquisition Corp. V (FTCVU) Income Statement Analysis – Financial Results
- West Wits Mining Limited (WMWWF) Income Statement Analysis – Financial Results
ASX Limited (ASXFF)
Industry: Financial - Data & Stock Exchanges
Sector: Financial Services
Website: https://www2.asx.com.au
About ASX Limited
ASX Limited operates as a multi-asset class and integrated exchange company in Australia and internationally. It operates markets for a range of asset classes, including equities, fixed income, commodities, and energy. The company provides listings, trading, clearing, settlement, registry, technical and information, and other post-trade services; securities and derivatives exchange, and ancillary services; and central counterparty clearing services. It is also involved in the depository, and settlement activities, as well as delivery-versus-payment clearing of financial products; and provision of data and technology services to intermediaries, banks, information vendors, and software developers to enable them to make decisions, offer services to their clients, and connect with one another. The company was incorporated in 1987 and is based in Sydney, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.59B | 1.42B | 1.04B | 962.30M | 949.00M | 871.30M | 826.70M | 765.70M | 746.30M | 687.10M | 646.20M | 611.20M | 758.40M | 611.66M | 582.16M | 529.54M | 598.23M | 538.07M | 291.96M | 265.97M | 227.88M | 195.11M | 195.65M | 192.60M | 0.00 | 0.00 | 0.00 | 119.89M |
| Cost of Revenue | 40.00M | 39.10M | 52.50M | 55.60M | 52.10M | 47.80M | 44.70M | 42.30M | 41.80M | 25.30M | 24.20M | 23.60M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 1.55B | 1.38B | 989.30M | 906.70M | 896.90M | 823.50M | 782.00M | 723.40M | 704.50M | 661.80M | 622.00M | 587.60M | 758.40M | 611.66M | 582.16M | 529.54M | 598.23M | 538.07M | 291.96M | 265.97M | 227.88M | 195.11M | 195.65M | 192.60M | 0.00 | 0.00 | 0.00 | 119.89M |
| Gross Profit Ratio | 97.49% | 97.25% | 94.96% | 94.22% | 94.51% | 94.51% | 94.59% | 94.48% | 94.40% | 96.32% | 96.26% | 96.14% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 100.00% |
| Research & Development | 0.00 | 0.33 | 0.68 | 0.68 | 0.66 | 0.65 | 0.63 | 0.66 | 0.67 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 85.50M | 307.20M | 235.70M | 214.30M | 202.50M | 186.90M | 56.70M | 155.20M | 144.80M | 145.60M | 133.20M | 132.10M | 134.50M | 126.25M | 122.24M | 119.40M | 138.50M | 143.71M | 122.69M | 123.12M | 103.87M | 96.81M | 79.33M | 70.05M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 251.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 336.90M | 307.20M | 235.70M | 214.30M | 202.50M | 186.90M | 56.70M | 155.20M | 144.80M | 145.60M | 133.20M | 132.10M | 134.50M | 126.25M | 122.24M | 119.40M | 138.50M | 143.71M | 122.69M | 123.12M | 103.87M | 96.81M | 79.33M | 70.05M | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 99.40M | -362.00M | -286.30M | -259.70M | -239.80M | 7.00M | -6.20M | 15.80M | 14.80M | 29.20M | 26.70M | 25.10M | 9.30M | 25.49M | 24.58M | 21.25M | 26.16M | 21.16M | 26.14M | 87.50M | 15.23M | -17.41M | -6.78M | -29.64M | 0.00 | 80.29M | 0.00 | -103.53M |
| Operating Expenses | 436.30M | 362.00M | 338.70M | 315.20M | 291.80M | 266.90M | 128.20M | 226.80M | 215.90M | 209.50M | 191.20M | 186.10M | 187.60M | 174.62M | 169.90M | 158.64M | 157.42M | 200.45M | 154.59M | 174.70M | 149.90M | 114.10M | 128.73M | 109.34M | 17.88M | 80.29M | 11.44M | 16.36M |
| Cost & Expenses | 436.30M | 401.10M | 338.70M | 315.20M | 291.80M | 266.90M | 128.20M | 226.80M | 215.90M | 209.50M | 191.20M | 186.10M | 187.60M | 174.62M | 169.90M | 158.64M | 157.42M | 200.45M | 154.59M | 174.70M | 149.90M | 114.10M | 128.73M | 109.34M | 17.88M | 80.29M | 11.44M | 16.36M |
| Interest Income | 539.70M | 403.90M | 54.90M | 60.70M | 151.30M | 216.20M | 170.90M | 150.50M | 146.30M | 151.40M | 135.60M | 147.60M | 16.10M | 160.67M | 128.16M | 284.59M | 298.39M | 290.14M | 32.51M | 9.21M | 7.22M | 6.46M | 4.32M | 4.65M | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 460.60M | 333.10M | 13.80M | 14.00M | 67.50M | 117.40M | 102.40M | 85.20M | 86.30M | 92.30M | 75.70M | 103.50M | 113.80M | 123.07M | 98.85M | 232.05M | 246.12M | 250.38M | 16.02M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 71.00K |
| Depreciation & Amortization | 40.00M | 39.10M | 52.40M | 55.50M | 52.00M | 47.80M | 42.10M | 42.30M | 42.70M | 38.60M | 33.80M | 30.40M | 30.40M | 25.57M | 23.67M | 15.04M | 18.92M | 14.88M | 10.48M | 16.17M | 16.57M | 17.29M | 18.70M | 18.51M | 17.88M | 0.00 | 11.44M | 16.36M |
| EBITDA | 1.18B | 819.40M | 758.90M | 719.00M | 817.50M | 836.40M | 786.60M | 719.00M | 735.10M | 697.10M | 651.10M | 628.20M | 626.60M | 648.76M | 588.67M | 691.79M | 784.27M | 678.69M | 216.98M | 107.44M | 94.56M | 98.29M | 85.62M | 101.77M | 0.00 | 80.29M | 0.00 | 153.24M |
| EBITDA Ratio | 74.31% | 74.50% | 76.45% | 78.71% | 90.15% | 99.89% | 109.14% | 97.64% | 98.50% | 101.46% | 100.76% | 102.78% | 82.62% | 106.07% | 101.12% | 130.64% | 131.10% | 126.13% | 74.32% | 40.39% | 41.49% | 50.38% | 43.76% | 52.84% | 0.00% | 0.00% | 0.00% | 127.82% |
| Operating Income | 1.15B | 1.02B | 744.10M | 701.90M | 803.50M | 822.50M | 860.20M | 705.30M | 692.40M | 658.50M | 617.30M | 597.80M | 596.20M | 623.19M | 565.00M | 676.75M | 765.35M | 663.81M | 206.50M | 91.27M | 77.98M | 81.01M | 66.92M | 83.27M | 137.18M | 80.29M | 27.39M | 136.88M |
| Operating Income Ratio | 72.57% | 71.75% | 71.42% | 72.94% | 84.67% | 94.40% | 104.05% | 92.11% | 92.78% | 95.84% | 95.53% | 97.81% | 78.61% | 101.89% | 97.05% | 127.80% | 127.94% | 123.37% | 70.73% | 34.32% | 34.22% | 41.52% | 34.20% | 43.23% | 0.00% | 0.00% | 0.00% | 114.17% |
| Total Other Income/Expenses | -472.90M | -331.20M | -66.20M | -69.50M | -134.70M | -117.40M | -170.20M | -88.90M | -129.00M | -130.90M | -109.50M | -103.80M | 65.90M | 63.09M | 53.89M | 59.57M | 78.43M | -250.38M | 53.11M | 112.78M | 25.23M | -427.00K | 7.02M | -8.81M | -201.00K | -37.73M | 0.00 | -85.86M |
| Income Before Tax | 681.50M | 462.70M | 730.30M | 687.90M | 720.80M | 705.10M | 642.10M | 616.40M | 606.10M | 566.20M | 541.60M | 494.30M | 482.40M | 500.12M | 466.15M | 444.70M | 519.23M | 413.43M | 190.48M | 204.05M | 116.57M | 80.58M | 82.68M | 74.46M | 83.36M | 42.56M | 10.69M | 17.67M |
| Income Before Tax Ratio | 42.84% | 32.59% | 70.10% | 71.48% | 75.95% | 80.93% | 77.67% | 80.50% | 81.21% | 82.40% | 83.81% | 80.87% | 63.61% | 81.77% | 80.07% | 83.98% | 86.80% | 76.84% | 65.24% | 76.72% | 51.16% | 41.30% | 42.26% | 38.66% | 0.00% | 0.00% | 0.00% | 14.74% |
| Income Tax Expense | 207.30M | 129.90M | 221.80M | 207.00M | 222.20M | 213.10M | 197.00M | 182.30M | 179.90M | 168.40M | 158.40M | 146.10M | 143.20M | 147.82M | 138.01M | 131.09M | 153.28M | 120.54M | 54.98M | 204.05M | 116.57M | 80.58M | 82.68M | 74.46M | 83.36M | 42.56M | 10.69M | 17.67M |
| Net Income | 474.20M | 317.30M | 508.50M | 480.90M | 498.60M | 492.00M | 445.10M | 434.10M | 426.20M | 397.80M | 383.20M | 348.20M | 339.20M | 352.30M | 328.14M | 313.61M | 365.95M | 292.89M | 135.50M | 165.47M | -532.00K | -413.00K | -100.00K | 2.00K | 53.62M | 37.73M | 16.70M | 15.67M |
| Net Income Ratio | 29.81% | 22.35% | 48.81% | 49.97% | 52.54% | 56.47% | 53.84% | 56.69% | 57.11% | 57.90% | 59.30% | 56.97% | 44.73% | 57.60% | 56.37% | 59.22% | 61.17% | 54.43% | 46.41% | 62.21% | -0.23% | -0.21% | -0.05% | 0.00% | 0.00% | 0.00% | 0.00% | 13.07% |
| EPS | 2.45 | 1.64 | 2.63 | 2.48 | 2.58 | 2.54 | 2.30 | 2.25 | 2.20 | 2.06 | 1.99 | 1.96 | 1.91 | 1.98 | 1.87 | 1.80 | 2.11 | 1.73 | 1.30 | 1.59 | -0.01 | 0.00 | 0.00 | 0.50 | 0.52 | 0.37 | 0.17 | 0.16 |
| EPS Diluted | 2.45 | 1.64 | 2.63 | 2.48 | 2.58 | 2.54 | 2.30 | 2.25 | 2.20 | 2.06 | 1.99 | 1.96 | 1.91 | 1.98 | 1.87 | 1.80 | 2.10 | 1.72 | 1.29 | 1.58 | -0.01 | 0.00 | 0.00 | 0.49 | 0.52 | 0.37 | 0.17 | 0.16 |
| Weighted Avg Shares Out | 193.71M | 193.58M | 193.58M | 193.59M | 193.59M | 193.58M | 193.51M | 193.42M | 193.41M | 193.41M | 193.02M | 175.29M | 177.89M | 177.51M | 175.07M | 173.87M | 173.69M | 169.42M | 104.35M | 104.31M | 103.63M | 103.58M | 103.07M | 102.85M | 102.61M | 102.39M | 99.78M | 102.18M |
| Weighted Avg Shares Out (Dil) | 193.67M | 193.58M | 193.58M | 193.59M | 193.59M | 193.58M | 193.51M | 193.42M | 193.41M | 193.41M | 193.02M | 175.29M | 177.89M | 177.51M | 175.07M | 173.97M | 174.02M | 170.00M | 104.75M | 104.98M | 103.63M | 103.58M | 103.07M | 102.85M | 102.61M | 102.39M | 99.78M | 102.18M |
Hot Money Monday: These are the most in-demand stocks on the ASX right now - Stockhead
Each Monday, Stockhead recaps which stocks are most heavily in demand by investors — running hot. The analysis is based on the Relative Strength Index (RSI), a technical gauge which measures how trading momentum is affecting the price action. A...
Aroa Biosurgery plans ASX listing to corner complex wound healing market
Auckland-based soft tissue regeneration company Aroa Biosurgery is set to list on the Australian Stock Exchange next month following an initial public offering aimed at raising $45 million from investors.
Virgin bondholders make their move, ASX moves lower
The S&P/ASX 200 dropped into negative territory around lunch time, with the financials sector now dragging away gains in healthcare and info tech.
Virgin bondholders make their move, ASX sitting higher
The S&P/ASX 200 is up 0.4% this morning. Industrial and energy sector stocks are dragging, while info tech is out-performing.
S&P/ASX 200 to open flat - BHP, AMP and QUB shares in focus | Rask Media
The S&P/ASX 200 (INDEXASX: XJO) is expected to open flat today. BHP Group Ltd (ASX:BHP), QUBE Holdings (ASX:QUB) and AMP Limited (ASX:AMP) are in the news.
ASX to rise; Nasdaq hits record
The Australian sharemarket is set to open modestly higher after US tech stocks rallied to a fresh high overnight; the Aussie dollar nears US70¢.
ASX 200 to open higher, ASX shares to watch Tuesday | Rask Media
Australia's S&P/ASX 200 (INDEXASX: XJO) is tipped to open higher today. Here is the news and the ASX shares to watch Tuesday morning.
ASX 200 flat: Altium update disappoints, Metcash posts full year loss
Altium Limited (ASX:ALU) and SEEK Limited (ASX:SEK) shares have been making waves on the ASX 200 on Monday. Here's why...
5 things to watch on the ASX 200 on Monday
Jumbo Interactive Ltd (ASX:JIN) and Metcash Limited (ASX:MTS) shares will be on watch on the ASX 200 on Monday. Here's why...
ASX to slide; RBA Lowe speaks; James Hardie lifts guidance
The Australian sharemarket is set to start the week on a negative footing, with futures pointing to weakness at the open. RBA governor Philip Lowe to speak on COVID-19 and the global economy. James Hardie boosted by US housing rebound.
Source: https://incomestatements.info
Category: Stock Reports